| Target |
Low affinity immunoglobulin gamma Fc region receptor III-A, IgG Fc receptor III-A, CD16-II, CD16a antigen, Fc-gamma RIII-alpha, Fc-gamma RIII, Fc-gamma RIIIa, FcRIII, FcRIIIa, FcgammaRIIIA, FcR-10, IgG Fc receptor III-2, CD16a, FCGR3A, CD16A, FCG3, FCGR3, IGFR3 |
| Function |
InVivoMAb Anti-Human CD16a/FCGR3A Antibody (LNK16)[LNK16] (ARO-A13012) is amouse monoclonalantibody detectingLow affinity immunoglobulin gamma Fc region receptor III-A, IgG Fc receptor III-A, CD16-II, CD16a antigen, Fc-gamma RIII-alpha, Fc-gamma RIII, Fc-gamma RIIIa, FcRIII, FcRIIIa, FcgammaRIIIA, FcR-10, IgG Fc receptor III-2, CD16a, FCGR3A, CD16A, FCG3, FCGR3, IGFR3inBlocking, ELISA. Suitable forHuman.HighlightsProtein A/G purified from cell culture supernatant.— Ensuring high specificity and minimal background.Multi-Application— Validated across multiple applications. |
